The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Antimalarial treatment may have a time‐dependent effect on lupus survival: Data from a multinational Latin American inception cohort
Open accessAbstract
Objective: To evaluate the beneficial effect of antimalarial treatment on lupus survival in a large, multiethnic, international longitudinal inception cohort. Methods: Socioeconomic and demographic characteristics, clinical manifestations, classification criteria, laboratory findings, and treatment variables were examined in patients with systemic lupus erythematosus (SLE) from the Grupo Latino Americano de Estudio del Lupus Eritematoso (GLADEL) cohort. The diagnosis of SLE, according to the American College of Rheumatology criteria, was assessed within 2 years of cohort entry. Cause of death was classified as active disease, infection, cardiovascular complications, thrombosis, malignancy, or other cause. Patients were subdivided by antimalarial use, grouped according to those who had received antimalarial drugs for at least 6 consecutive months (user) and those who had received antimalarial drugs for <6 consecutive months or who had never received antimalarial drugs (nonuser). Results: Of the 1,480 patients included in the GLADEL cohort, 1,141 (77%) were considered antimalarial users, with a mean duration of drug exposure of 48.5 months (range 6–98 months). Death occurred in 89 patients (6.0%). A lower mortality rate was observed in antimalarial users compared with nonusers (4.4% versus 11.5%; P< 0.001). Seventy patients (6.1%) had received antimalarial drugs for 6–11 months, 146 (12.8%) for 1–2 years, and 925 (81.1%) for >2 years. Mortality rates among users by duration of antimalarial treatment (per 1,000 person‐months of followup) were 3.85 (95% confidence interval [95% CI] 1.41–8.37), 2.7 (95% CI 1.41–4.76), and 0.54 (95% CI 0.37–0.77), respectively, while for nonusers, the mortality rate was 3.07 (95% CI 2.18–4.20) (P for trend < 0.001). After adjustment for potential confounders in a Cox regression model, antimalarial use was associated with a 38% reduction in the mortality rate (hazard ratio 0.62, 95% CI 0.39–0.99). Conclusion: Antimalarial drugs were shown to have a protective effect, possibly in a time‐dependent manner, on SLE survival. These results suggest that the use of antimalarial treatment should be recommended for patients with lupus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
Ruiz-Irastorza, G., Egurbide, M.-V., Pijoan, J.-I., Garmendia, M., Villar, I., Martinez-Berriotxoa, A., Erdozain, J.-G., & Aguirre, C. (2006) · Lupus · doi:10.1177/0961203306071872 · Cited by 411
Hydroxychloroquine Reverses Thrombogenic Properties of Antiphospholipid Antibodies in Mice
Edwards, M. H., Pierangeli, S., Liu, X., Barker, J. H., Anderson, G., & Harris, E. N. (1997) · Circulation · doi:10.1161/01.cir.96.12.4380 · Cited by 250
Kaiser, R., Cleveland, C. M., & Criswell, L. A. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.093013 · Cited by 244
Cited by
Schoenfeld, S. R., Kasturi, S., & Costenbader, K. H. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2012.12.002 · Cited by 370
Magder, L. S., & Petri, M. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws130 · Cited by 289
Epidemiology of systemic lupus erythematosus
Pons-Estel, G. J., Ugarte-Gil, M. F., & Alarcón, G. S. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1327352 · Cited by 259
Self-citationLane, J. C. E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M. T. F., Alghoul, H., Alser, O., Alshammari, T. M., Biedermann, P., Banda, J. M., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30276-9 · Cited by 258
Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome
Belizna, C. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.12.006 · Cited by 118
Metadata
- Authors
- Shinjo, S. K., Bonfá, E., Wojdyla, D., Borba, E. F., Ramirez, L. A., Scherbarth, H. R., Brenol, J. C. T., Chacón‐Diaz, R., Neira, O. J., Berbotto, G. A., de la Torre, I. G., Acevedo‐Vázquez, E. M., Massardo, L., Barile‐Fabris, L. A., Caeiro, F., Silveira, L. H., Sato, E. I., Buliubasich, S., Alarcón, G. S., & Pons‐Estel, B. A.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2010-02-25
- Volume
- 62
- Issue
- 3
- Pages
- 855-862
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2088887888
- Cited by
- 213
- References
- 3
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antimalarial treatment may have a time‐dependent effect on lupus survival: Data from a multinational Latin American inception cohort. https://app.cochat.ai/papers/10.1002/art.27300
- The paper
- Shinjo, S. K., Bonfá, E., Wojdyla, D., Borba, E. F., Ramirez, L. A., Scherbarth, H. R., Brenol, J. C. T., Chacón‐Diaz, R., Neira, O. J., Berbotto, G. A., de la Torre, I. G., Acevedo‐Vázquez, E. M., Massardo, L., Barile‐Fabris, L. A., Caeiro, F., Silveira, L. H., Sato, E. I., Buliubasich, S., Alarcón, G. S., & Pons‐Estel, B. A. (2010). Antimalarial treatment may have a time‐dependent effect on lupus survival: Data from a multinational Latin American inception cohort. Arthritis & Rheumatism. https://doi.org/10.1002/art.27300
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.